FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
This is the first update to the original CTS communication distributed on July 6th. As previously co...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...